M&A Deal Summary |
|
|---|---|
| Date | 2017-01-23 |
| Target | iBliss |
| Sector | Life Science |
| Buyer(s) | Easton Pharmaceuticals |
| Deal Type | Add-on Acquisition |
SEARCH BY
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and new growing industries. The Company previously developed and owned an FDA-approved wound-healing drug and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica SA de C.V. and together, own the exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products from CommonSense of Israel, along with two generic cancer drugs, Paclitaxel and Docetaxel from BioLyse Pharma of St. Catherine's Ontario, Canada. The company's list of woman's diagnostic, treatment and preventative care products include, Gynofit, licensed from a Swiss based manufacturer, VS-Sense and AmnioSense, both patented products that are licensed from Israel based CommonSense. Easton has entered into a distribution agreement with Europe based Gedeon Richter for Gynofit. Easton Pharmaceuticals was founded in 1997 and is based in Toronto, Canada.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Ontario M&A | 1 of 1 |
| Country: Canada M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
